Publication | Open Access
A novel artificial intelligence network to assess the prognosis of gastrointestinal cancer to immunotherapy based on genetic mutation features
19
Citations
38
References
2024
Year
The GMS developed here can reliably predict survival benefit for gastrointestinal cancer patients on ICIs therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1